Hot Stock
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige
EVOGENE WKN: A0Q7UP ISIN: IL0011050551 Kürzel: E3V Forum: Aktien Thema: Hauptdiskussion
1,62 USD
+1,25 %+0,02
23. Nov, 02:00:00 Uhr,
Nasdaq
Kommentare 29
Summer.76,
06.07.2021 15:47 Uhr
0
Evogene : AgPlenus Announces Positive Results for a Herbicide Resistance Trait to its Leading Herbicide Product Candidate
https://www.marketscreener.com/quote/stock/EVOGENE-LTD-56536833/news/Evogene-nbsp-AgPlenus-Announces-Positive-Results-for-a-Herbicide-Resistance-Trait-to-its-Leading-H-35797014/
Summer.76,
11.08.2021 13:23 Uhr
0
Evogene Reports Second Quarter 2021 Financial Results
https://finance.yahoo.com/news/evogene-reports-second-quarter-2021-110000165.html
https://www.earningswhispers.com/epsdetails/evgn
Evogene Ltd Ord (EVGN) reported a 2nd Quarter June 2021 loss of $0.15 per share on revenue of $0.1 million. on revenue of $0.3 million. Revenue fell 54.7% compared to the same quarter a year ago.
Summer.76,
31.08.2021 17:39 Uhr
0
Evogene : Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in Israel
https://www.marketscreener.com/quote/stock/EVOGENE-LTD-120962472/news/Evogene-Canonic-Announces-Pre-Launch-of-its-First-Generation-Medical-Cannabis-Products-in-Israel-36288842/
Pre-launch of G-nnovation product line to a limited number of patients;
Full commercial launch expected in 2022
Summer.76,
29.09.2021 15:40 Uhr
0
https://www.marketscreener.com/quote/stock/EVOGENE-LTD-120962472/news/Evogene-Lavie-Bio-and-United-Agronomy-Announce-Signing-of-Distribution-Agreement-for-Lavie-Bio-s-I-36548784/
Summer.76,
19.10.2021 15:48 Uhr
0
Evogene : Canonic moves ahead of schedule with the full commercial launch of its G-nnovation products, following positive feedback from patients during the company's pre-launch campaign - Form 6-K
https://www.marketscreener.com/quote/stock/EVOGENE-LTD-120962472/news/Evogene-Canonic-moves-ahead-of-schedule-with-the-full-commercial-launch-of-its-G-nnovation-product-36715825/
Summer.76,
26.05.2021 17:22 Uhr
0
Evogene Reports First Quarter 2021 Financial Results
https://www.marketscreener.com/quote/stock/CORTEVA-INC-59241389/news/Corteva-nbsp-Evogene-Reports-First-Quarter-2021-Financial-Results-Evogene-33357979/
Evogene Q1 EPS $(0.17) Up From $(0.24) YoY, Sales $333.00K Beat $300.00K Estimate
https://www.benzinga.com/news/earnings/21/05/21294854/evogene-q1-eps-0-17-up-from-0-24-yoy-sales-333-00k-beat-300-00k-estimate
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.17) per share. This is a 29.17 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $333.00 thousand which beat the analyst consensus estimate of $300.00 thousand by 11.00 percent. This is a 344.00 percent increase over sales of $75.00 thousand the same period last year.
Summer.76,
13.04.2021 19:04 Uhr
0
Biomica Announces Positive Pre-Clinical Results, Demonstrating Efficacy of BMC128 in Melanoma
https://www.prnewswire.com/news-releases/biomica-announces-positive-pre-clinical-results-demonstrating-efficacy-of-bmc128-in-melanoma-301267404.html
Biomica's live biotherapeutic drug candidate, BMC128, significantly increased anti-tumor activity in combination with Immune Checkpoint Inhibitors in Melanoma. First-in-human, proof of concept study expected later this year
Summer.76,
18.03.2021 7:19 Uhr
0
Plastomics and Evogene's Ag-Seed division enter a collaborative agreement targeting novel insect control traits for soybean
https://www.prnewswire.com/il/news-releases/plastomics-and-evogenes-ag-seed-division-enter-a-collaborative-agreement-targeting-novel-insect-control-traits-for-soybean-301249298.html
The parties will test in soybean, Evogene's candidate genes for insect control utilizing Plastomics' novel chloroplast transformation technology ...
nils28,
05.03.2021 15:58 Uhr
0
Heftig, wie der Wert hier zerissen wird seit Tagen. Mehr als 50% gefallen. Komplette Übertreibung. Gut gelaufen hin oder her...
Summer.76,
03.03.2021 15:10 Uhr
0
Evogene Reports Fourth Quarter and Full Year 2020 Financial Results
https://www.prnewswire.com/news-releases/evogene-reports-fourth-quarter-and-full-year-2020-financial-results-301239537.html
Summer.76,
05.01.2021 16:26 Uhr
0
Evogene Provides 2020 Year-End Update for CRISPR-IL Consortium
https://finance.yahoo.com/news/evogene-provides-2020-end-crispr-120000314.html
Summer.76,
29.12.2020 13:24 Uhr
0
Lavie Bio Provides Product Pipeline Update for 2020
https://www.prnewswire.com/news-releases/lavie-bio-provides-product-pipeline-update-for-2020-301198936.html
LAV211 bio-stimulant advancing towards anticipated 2022 commercial launch in spring wheat; Product advancement achieved in multiple programs
Lavie Bio Ltd. (Lavie Bio), a leading ag-biologicals company focusing on improving food quality, sustainability and agriculture productivity through the introduction of microbiome-based products, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), has announced an update on certain advancements achieved in its pipeline in 2020, including phase advancement of bio-stimulant LAV211, towards an anticipated commercial launch in 2022.
...
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | Trading- und Aktien-Chat | ||
| 2 | MICROSTRATEGY Hauptdiskussion | +1,69 % | |
| 3 | für alle, die es ehrlich meinen beim Traden. | ||
| 4 | MicroStrategy | +1,69 % | |
| 5 | CFC INDUSTRIE Hauptdiskussion | -3,70 % | |
| 6 | CoinBase (Future ExChange) | +0,09 % | |
| 7 | ARM | +0,15 % | |
| 8 | NuGen Hauptforum | ±0,00 % | |
| 9 | BLOOM ENERGY A Hauptdiskussion | +0,16 % | |
| 10 | BTC/USD Hauptdiskussion | -0,20 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | MICROSTRATEGY Hauptdiskussion | +1,69 % | |
| 2 | MicroStrategy | +1,69 % | |
| 3 | CFC INDUSTRIE Hauptdiskussion | -3,70 % | |
| 4 | CoinBase (Future ExChange) | +0,09 % | |
| 5 | BLOOM ENERGY A Hauptdiskussion | +0,16 % | |
| 6 | Nio für normale Kommunikation | ±0,00 % | |
| 7 | ARM | +0,15 % | |
| 8 | NuGen Hauptforum | ±0,00 % | |
| 9 | EVOTEC Hauptdiskussion | ±0,00 % | |
| 10 | Cardiol Therapeutics Registered (A) Hauptdiskussion | ±0,00 % | Alle Diskussionen |